NCT02621242View on ClinicalTrials.gov

Effects of the Anti-HIV Pill Truvada on Gene Transcription in the Gastrointestinal Tract of HIV-uninfected Individuals

CompletedOBSERVATIONAL
Enrollment

9

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2017

Conditions
HIV
Interventions
PROCEDURE

Upper endoscopy

Upper endoscopy with biopsies

PROCEDURE

Anoscopy

Anoscopy with biopsies

DRUG

Truvada

Truvada (tenofovir/emtricitabine) daily as HIV pre-exposure prophylaxis. This medication will not be provided by the study.

Trial Locations (1)

98104

Harborview Medical Center, Seattle

All Listed Sponsors
lead

University of Washington

OTHER

NCT02621242 - Effects of the Anti-HIV Pill Truvada on Gene Transcription in the Gastrointestinal Tract of HIV-uninfected Individuals | Biotech Hunter | Biotech Hunter